Clinical Trials Sponsored by BioFilm Control

Total 6744 results

AHS Cancer Control Alberta

Completed

Megavoltage CT (MVCT) Imaging for Intracavitary Radiation Treatment in Cervix Cancer

Cervix Cancer

Canada
AHS Cancer Control Alberta

Completed

Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function

Head and Neck Cancer

Canada
AHS Cancer Control Alberta

Withdrawn

Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma

Glioblastoma
AHS Cancer Control Alberta

Unknown

Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer

Pancreas Cancer

Canada
AHS Cancer Control Alberta

Unknown

Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer

Small Cell Lung Cancer

Canada
AHS Cancer Control Alberta

Unknown

A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer (Panc001)

Metastatic Pancreas Cancer

Canada
AHS Cancer Control Alberta

Terminated

Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection

Breast Neoplasms

Canada
AHS Cancer Control Alberta

Not yet recruiting

Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)

Arthritis | Arthralgia
AHS Cancer Control Alberta

Not yet recruiting

Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo) (IMPACT 1)

Diarrhea | Advanced Melanoma | Immune-related Adverse Event | Advanced Rectal Carcinoma

Canada
AHS Cancer Control Alberta

Recruiting

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

Pancreatic Cancer | Cholangiocarcinoma | Biliary Tract Cancer | Hepatocellular Cancer

Canada
AHS Cancer Control Alberta

Not yet recruiting

Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)

Breast Cancer Triple Negative

Canada
AHS Cancer Control Alberta

Recruiting

Tamoxifen Versus Etoposide After First Recurrence in GBM Patients

Glioblastoma Multiforme

Canada
AHS Cancer Control Alberta

Recruiting

Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases (ACT-FAST)

Brain Metastases, Adult

Canada
AHS Cancer Control Alberta

Recruiting

MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1)

Cancer

Canada
AHS Cancer Control Alberta

Active, not recruiting

A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers (PRESTO)

Estrogen Receptor Positive Breast Cancer

Canada
AHS Cancer Control Alberta

Terminated

[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours

Renal Cell Carcinoma | Neuroendocrine Tumours

Canada
AHS Cancer Control Alberta

Completed

Breast Cancer and Exercise Trial in Alberta (BETA)

Breast Neoplasms

Canada
AHS Cancer Control Alberta

Completed

Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma

Uveal Melanoma

Canada
Physio-Control
GE Healthcare

Completed

The Haemodynamic Effects of Mechanical Standard and Active Chest Compression-decompression During Out-of-hospital CPR

Cardiac Arrest

Norway
AHS Cancer Control Alberta

Unknown

A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed Implant

Prostate Cancer

Canada
AHS Cancer Control Alberta

Completed

Trial of Combined Aerobic and Resistance Exercise in Breast Cancer Survivors

Breast Cancer

Canada
AHS Cancer Control Alberta

Unknown

The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer

Prostate Cancer

Canada
AHS Cancer Control Alberta

Completed

Study of Tomotherapy in Patients With Benign Brain Tumour

Brain Neoplasms

Canada
AHS Cancer Control Alberta

Completed

Tomotherapy Treatment for Mesothelioma

Mesothelioma

Canada
AHS Cancer Control Alberta

Withdrawn

A Phase III Study of Re-Irradiation in Recurrent Glioblastoma

Recurrent Glioblastoma

Canada
AHS Cancer Control Alberta

Terminated

Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer

Prostate Cancer

Canada
AHS Cancer Control Alberta

Terminated

An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment

Breast Cancer

Canada
AHS Cancer Control Alberta

Completed

Image and Dosimetry Related Research of Department of Medical Physics, Cross Cancer Institute

Healthy

Canada
AHS Cancer Control Alberta

Terminated

Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy

Cardiac Toxicity | Genetic Markers | Breast and Skin Motion

Canada
AHS Cancer Control Alberta

Withdrawn

TORI 104 Pre-Surgical Dasatinib

Breast Cancer

Canada
AHS Cancer Control Alberta

Withdrawn

Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Low Tumor Burden Untreated or Indolent NHL

Lymphoma

Canada
AHS Cancer Control Alberta

Unknown

Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy

Lung Neoplasm | Cell Hypoxia

Canada
AHS Cancer Control Alberta

Unknown

Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients

Colorectal Cancer | Colorectal Carcinoma | Neoplasms, Colorectal

Canada
King's College London
Calouste Gulbenkian Foundation; Centro Hospitalar Lisboa Central

Completed

Feasibility of Home vs. Hospital Based Resistance Training for Advanced Cancer Patients

Advanced Cancer

United Kingdom
San Giovanni Addolorata Hospital
Centro per la Lotta Contro l'Infarto - Fondazione Onlus

Unknown

Relationship Between OCT Coronary Plaque Morphology and Clinical Outcome (CLIMA)

Coronary Artery Disease

Spain, Italy, Poland
Centers for Disease Control and Prevention
University of North Carolina, Chapel Hill; Kamuzu Central Hospital

Completed

Breastfeeding, Antiretroviral, and Nutrition Study

HIV Infections

Malawi
AHS Cancer Control Alberta
Celgene

Active, not recruiting

A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer (AX-CSARC)

Unresectable Biliary Tract Cancer

Canada
AHS Cancer Control Alberta
Sanofi

Completed

First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer. (IXOGoo1)

Gastric Adenocarcinoma | Gastrointestinal Neoplasm

Canada
AHS Cancer Control Alberta
Pfizer

Completed

SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial (SPRUCE)

Bladder Cancer | Urothelial Cancer | Adult

Canada
Tufts Medical Center
Immune Control

Terminated

Fluphenazine Decanoate for Psoriasis

Psoriasis

United States
AHS Cancer Control Alberta
Rehabtronics

Terminated

Pressure injuRy preventiOn by inTermittent EleCtrical sTimulation (PROTECT)

Pressure Injury

Canada
Tufts Medical Center
Immune Control

Completed

Fluphenazine Hydrochloride for Psoriasis (FP-CL2)

Psoriasis

United States
National Center for AIDS/STD Control and Prevention...
Sichuan Center for Disease Control and Prevention; Guizhou Center for Disease... and other collaborators

Unknown

(Men Who Have Sex With Men) MSM Community Intervention Trial

HIV | Syphilis | Herpesvirus 2, Human

China
Universidad Nacional Andres Bello
Centro para la Prevención y Control del Cáncer (CECAN), Santiago, Chile

Recruiting

Effects of Telemonitoring in Quality of Life Amongst Cancer Patients (EQUALITE)

Quality of Life | Cancer | Telemedicine | Symptoms and Signs | Telemonitoring

Chile
Universidad Nacional Andres Bello
Centro para la Prevención y Control del Cáncer (CECAN), Santiago, Chile

Recruiting

Telemonitoring Platforms and Chemotherapy-Associated Toxicity (DETECT)

Cancer | Chemotherapeutic Agent Toxicity

Chile
Helsinki University Central Hospital
Central Finland Central Hospital

Completed

Non-interventional Follow-up Versus Fluid Bolus in RESPONSE to Oliguria in the Critically Ill (RESPONSE)

Sepsis | Acute Kidney Injury | Critically Ill | Oliguria

Finland
Centers for Disease Control and Prevention, China
Centers for Disease Control and Prevention; Shandong Province Centers for Disease...

Unknown

Shandong and Ministry of Health Action on Salt and Hypertension Project (SMASH)

Hypertension

China
National Center for AIDS/STD Control and Prevention...
Sichuan Center for Disease Control and Prevention; Guizhou Center for Disease... and other collaborators

Unknown

Injecting Drug Use Community Intervention Trial

HIV Infections | Hepatitis C | HIV | HSV-2 | Syphilis

China
Albino Maia
Centro Hospitalar Lisboa Ocidental; Centro Hospitalar De São João, E.P.E.; Centro... and other collaborators

Recruiting

Deep Brain Stimulation-Induced Mania in Parkinson's Disease (BPD_DBS)

Parkinson Disease | Mania

Portugal
BioFire Diagnostics, LLC
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Implementation of a Molecular Diagnostic for Pediatric Acute Gastroenteritis: The FilmArray GI Panel IMPACT Study (IMPACT)

Infectious Gastroenteritis

United States

Clinical Trials Sponsored by BioFilm Control

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations